Select a community
All Communities
Home > Community Treatment Reports > Carbidopa Treatment Report
What is Carbidopa?

Carbidopa is a dopamine agonist. It is generally given with levodopa in the treatment of parkinsonism to enable a lower dosage of levodopa to be used and a more rapid response to be obtained and to decrease side effects.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Treat Parkinson's 6 0
Nausea 6 1
Stiffness/Spasticity 1 0
Other 1 0

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
0 0%
Mild
1 100%
None
0 0%

Most commonly reported side effects

Sleepiness
1 100%
  • Mild
  • Moderate
  • Severe

Dosages

  25 mg all the time (24/7) 20 mg daily 25 mg daily 50 mg daily 75 mg daily 100 mg daily 150 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 4 Number of Patients: 4 2 Number of Patients: 2 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Carbidopa (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice
2 67% Doctor's advice: 67%
Did not seem to work
1 33% Did not seem to work: 33%
Side effects too severe
1 33% Side effects too severe: 33%
Course of treatment ended
1 33% Course of treatment ended: 33%

See all 3 patients who’ve stopped taking Carbidopa

Currently Taking Carbidopa

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
0
2
2
0
0

Stopped Taking Carbidopa

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
0
0
0
1
1

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
1 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
1 100%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
1 100%
$25-49
0 0%
< $25
0 0%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 23, 2009.